Evolution of the Average Target: BioRestorative Therapies, Inc.

Evolution of the Target Price: BioRestorative Therapies, Inc.

Changes in Analyst Recommendations: BioRestorative Therapies, Inc.

3d4cc24863aa4aa828f1.U5XVNhVCMe8ZAlzlx-xRBWbcWtaMvdjGmCD24N0N4S4.PsyXeFwhYYhPQxiMmJ89YDKMY7D76e3w7RGlse1rhE8j5JhRYDprnUtvMw~4b09349a132a653cf69c81e8667c37ec

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +3,821.57%
+12.99%
+17.61%
+52.66%
+28.69%
+2.59%
+20.25%
-13.44%
+5.12%
-2.09%
Average +394.59%
Weighted average by Cap. +16.46%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.2040USD
Average target price
8.000USD
Spread / Average Target
+3,821.57%
High Price Target
15.00USD
Spread / Highest target
+7,252.94%
Low Price Target
1.000USD
Spread / Lowest Target
+390.20%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Roth Capital Partners
Maxim
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.2040USD
Average target price
8.000USD
Spread / Average Target
+3,821.57%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BRTX Stock
  4. Consensus BioRestorative Therapies, Inc.